Direct Oral Anticoagulants (DOACs) are Non-Inferior to Vitamin K Antagonists for Patients Undergoing Transcatheter Aortic Valve Replacement with Indications of Anticoagulation

Direct Oral Anticoagulants (DOACs) are Non-Inferior to Vitamin K Antagonists for Patients Undergoing Transcatheter Aortic Valve Replacement with Indications of Anticoagulation

Background: The best anticoagulation choice for patients undergoing transcatheter aortic valve replacement (TAVR) with indications of oral anticoagulation (OAC) remains uncertain. We carried out a comprehensive analysis adopting updated evidence that investigated the efficacy and safety of direct or...

Full description

Bibliographic Details
Main Authors: Jia Wang, Feng-Ying Zhang, Li Liu, Mang-Mang Pan, Chi Zhang, Jin Chen, Yuan Bian, Hou-Wen Lin, Zhi-Chun Gu
Format: Article
Language:English
Published: IMR Press 2022-10-01
Series:Reviews in Cardiovascular Medicine
Subjects:
valve replacement
anticoagulation
edoxaban
apixaban
thromboembolism
hemorrhage
Online Access:https://www.imrpress.com/journal/RCM/23/10/10.31083/j.rcm2310346

Internet

https://www.imrpress.com/journal/RCM/23/10/10.31083/j.rcm2310346

Similar Items